Prediction: $1,000 in NuScale Power Today Could Be Worth This Much by 2030

NuScale Power could regain its prior $57.42 52-week high by 2030, implying a hypothetical $1,000 investment at $10 could reach $5,742, contingent on commercial execution. The company, whose NRC-certified SMR design has yet to achieve first deployment, could supply up to 72 modules through ENTRA1 Energy for TVA projects across multiple sites. NuScale shares previously sold off roughly 83% as nuclear deployment timelines disappointed investors, making a binding TVA agreement a key potential catalyst rather than a confirmed revenue source.

Analysis

SMR remains an option on a multi-year nuclear buildout rather than a conventional revenue-growth equity. The relevant valuation inflection is not a non-binding development pathway but a bankable contract with defined module count, site allocation, EPC responsibility, financing, and customer credit support. Until those terms emerge, the stock’s sensitivity will be dominated by retail/AI-power sentiment and liquidity, creating a high beta profile disconnected from near-term earnings.

A large TVA-linked award would validate NuScale’s commercial architecture but would not automatically translate into high-margin revenue: project financing, cost-overrun allocation, manufacturing capacity, and delivery guarantees determine whether backlog deserves a material multiple re-rating. The second-order beneficiary is likely Fluor (FLR), NuScale’s majority owner and engineering partner, which has a more diversified earnings base and could capture engineering/procurement work with materially lower single-asset risk. Larger reactor and fuel-cycle incumbents—including BWXT and Cameco (CCJ)—may also benefit from a broader domestic nuclear procurement cycle without requiring NuScale-specific execution.

Over the next 1-3 months, SMR can rally sharply on contract-language headlines, but the absence of disclosed economics or a credible funding structure should fade such moves. Over 6-18 months, the key risk is that power-demand urgency favors faster-to-permit alternatives—gas turbines, renewables plus storage, and life extensions of existing reactors—while nuclear project timelines remain long. The bullish thesis is falsified by another project delay, customer withdrawal, equity issuance to fund corporate burn, or contract terms that leave NuScale bearing fixed-price construction exposure.

Contrarian view: the market may be underestimating the strategic value of an NRC-certified design, but it is also likely overestimating the probability that certification converts efficiently into deployable, financeable projects. A return to a prior sentiment-driven peak requires not just commercial news but a credible path to repeatable module economics; the first deal may prove the technology while still exposing weak project returns.

Key Decisions for Investors

• Do not chase SMR on preliminary TVA/ENTRA1 headlines. Initiate only after a binding agreement discloses module volume, financing and risk allocation; size as a 6-18 month venture-style position, with a hard thesis review if no definitive contract or funding milestone occurs within two quarters.
• Prefer long FLR over SMR for nuclear-project optionality: FLR has potential EPC/engineering upside from deployment while diversified operations reduce binary reactor-commercialization risk. Reassess if disclosed project terms bypass Fluor or impose material fixed-price liability.
• For a high-risk catalyst trade, use defined-risk SMR call spreads dated 9-15 months out rather than common equity, entered only after confirmation that negotiations have moved to binding documentation. Maximum loss should be limited to premium; avoid structures that assume a return to prior highs.
• Monitor SMR cash burn, share count, backlog quality, customer deposits and any disclosed cost-overrun guarantees at each earnings release. A dilutive capital raise before firm project financing is a bearish trigger and supports avoiding or shorting post-headline rallies.
• Use BWXT and CCJ as less binary watch-list beneficiaries of a U.S. nuclear procurement acceleration; upgrade only if policy support is accompanied by actual utility orders, fuel contracting, or life-extension approvals rather than AI-demand rhetoric.